Larry K. Benedict
Keine laufenden Positionen mehr
Profil
Larry K.
Benedict worked as a Finance Director & Controller at Seagen Inc. from 2000 to 2008.
Prior to that, he was a Principal at Bristol Myers Squibb Co. from 1990 to 1997.
He also worked as a Finance Manager at SmithKline Beecham Clinical Laboratories from 1997 to 1998 and as a Chief Financial Officer at Sensible Solutions, Inc. from 1998 to 2000.
From 2016 to 2019, he served as the Chief Accounting Officer & Executive VP at Lundbeck Seattle BioPharmaceuticals, Inc. Benedict received his undergraduate degree from Central Washington University in 1982.
Ehemalige bekannte Positionen von Larry K. Benedict
| Unternehmen | Position | Ende |
|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Finanzdirektor/CFO | 06.10.2016 |
| SEAGEN INC. | Finanzdirektor/CFO | 01.01.2008 |
Sensible Solutions, Inc.
 Sensible Solutions, Inc. Packaged SoftwareTechnology Services Part of Tectura Corp., Sensible Solutions, Inc. develops small business and customer relationship management software. The company is based in Kent, WA. Sensible Solutions was acquired by Tectura Corp. on February 09, 2004. | Finanzdirektor/CFO | 01.01.2000 |
SmithKline Beecham Clinical Laboratories
 SmithKline Beecham Clinical Laboratories Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, SmithKline Beecham Clinical Laboratories is a British company that provides diagnostic services, testing, and information. The company is based in Heston, UK. | Corporate Officer/Principal | 01.01.1998 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1997 |
Ausbildung von Larry K. Benedict
| Central Washington University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
SmithKline Beecham Clinical Laboratories
SmithKline Beecham Clinical Laboratories Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, SmithKline Beecham Clinical Laboratories is a British company that provides diagnostic services, testing, and information. The company is based in Heston, UK. | Commercial Services |
Sensible Solutions, Inc.
Sensible Solutions, Inc. Packaged SoftwareTechnology Services Part of Tectura Corp., Sensible Solutions, Inc. develops small business and customer relationship management software. The company is based in Kent, WA. Sensible Solutions was acquired by Tectura Corp. on February 09, 2004. | Technology Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
